Marcia Belvin, SVP, Chief Scientific Officer: CytomX Therapeutics CTMX Sell · Filed 03/19

Trade details

Type: Insider sale
Amount: $202,178.64
Shares · price: 31,492 sh · $6.42 a share
Held after: 300,760 sh
Stock: CytomX Therapeutics CTMX
Person: Marcia BelvinSVP, Chief Scientific Officer
Trade date: 26/03/17
Filed: 26/03/19
Days to filing: 2 days

Sold 9.5% of holdings

Share of holding sold: 9.5%

CytomX Therapeutics trades, last 26 weeks

What else happened in CytomX Therapeutics around then

Filed or reported within 30 days of the trade day · 02/15~04/16

Marcia Belvin's recent trades

Marcia BelvinSVP, Chief Scientific Officer
SellCytomX Therapeutics
Sell
CytomX Therapeutics
CTMX
$37.3K
13,884 sh
$37.3K
Filed 25/06/17
Traded 25/06/16
Marcia BelvinSVP, Chief Scientific Officer
SellCytomX Therapeutics
Sell
CytomX Therapeutics
CTMX
$11.7K
19,512 sh
$11.7K
Filed 25/03/20
Traded 25/03/18
Marcia BelvinSVP, Chief Scientific Officer
SellCytomX Therapeutics
Sell
CytomX Therapeutics
CTMX
$5,143
4,181 sh
$5,143
Filed 24/08/22
Traded 24/08/20
Marcia BelvinSVP, Chief Scientific Officer
SellCytomX Therapeutics
Sell
CytomX Therapeutics
CTMX
$26.7K
12,795 sh
$26.7K
Filed 24/03/21
Traded 24/03/19
Marcia BelvinSVP, Chief Scientific Officer
SellCytomX Therapeutics
Sell
CytomX Therapeutics
CTMX
$5,626
4,077 sh
$5,626
Filed 23/12/22
Traded 23/12/20